A share price of Disc Medicine Inc [IRON] is currently trading at $41.00, down -0.75%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The IRON shares have gain 5.94% over the last week, with a monthly amount drifted -22.39%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Morgan Stanley upgraded its rating to Overweight on November 05, 2024, and kept the price target unchanged to $85. On November 04, 2024, upgrade upgraded it’s rating to Strong Buy and revised its price target to $110 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $89 on October 23, 2024. Scotiabank initiated its recommendation with a Sector Outperform. Wells Fargo started tracking with a Overweight rating for this stock on August 22, 2024, and assigned it a price target of $75. In a note dated April 01, 2024, Raymond James downgraded an Outperform rating on this stock but restated the target price of $40.
Disc Medicine Inc experienced fluctuations in its stock price throughout the past year between $25.64 and $68.73. Currently, Wall Street analysts expect the stock to reach $90.33 within the next 12 months. Disc Medicine Inc [NASDAQ: IRON] shares were valued at $41.00 at the most recent close of the market. An investor can expect a potential return of 120.32% based on the average IRON price forecast.
Analyzing the IRON fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.22, Equity is -0.25 and Total Capital is -0.27. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 39.76 points at the first support level, and at 38.51 for the second support level. However, for the 1st resistance point, the stock is sitting at 41.69, and for the 2nd resistance point, it is at 42.37.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Disc Medicine Inc [NASDAQ:IRON] is 21.17. As well, the Quick Ratio is 21.17, while the Cash Ratio is 8.25.
Transactions by insiders
Recent insider trading involved Ashiya Mona, Director, that happened on Mar 24 ’25 when 5738.0 shares were sold. Director, ORBIMED ADVISORS LLC completed a deal on Mar 24 ’25 to sell 5738.0 shares. Meanwhile, Director Ashiya Mona sold 39656.0 shares on Mar 19 ’25.
